Heart failure & cardiomyopathies

Risk of heart failure in inflammatory bowel disease: a Swedish population-based study

Eur Heart JPublished Population-based matched cohort study

Main finding · HFResult — go to the resultAdjusted hazard ratio 1.19 95% CI 1.15–1.23

Authors' conclusion

Patients with IBD had a moderately higher risk of developing HF for ≥20 years after IBD diagnosis than the general population.

Study context

Population
Patients with biopsy-confirmed inflammatory bowel disease (IBD) in Sweden, followed until 31 December 2019matched cohort
Participants
81,749 / 382,190 / 95,239
Exposure
IBD vs matched general population reference individuals
  • IBDn = 81,749
  • Reference individualsn = 382,190reference
  • Siblingsn = 95,239reference
Outcome
Incident HF
Follow-up
Median 12.4 years
Methodological detailsnationwide, matched with up to five general population reference individuals, sibling-controlled analysis
  • Nationwide
  • Matched with up to five general population reference individuals
  • Sibling-controlled analysis

Main finding

HF

Adjusted hazard ratio

1.19

95% CI 1.15–1.23

Events by group

IBD

50.3/10 000 person-years

5582 of 81 749

Reference individuals

37.9

20 343 of 382 190

IBDvs Reference individuals
aHR 1.19 (95% CI 1.15–1.23)

As reported in the abstract

Observational data: associations, not effects.

Further findings

OutcomeaHR (CI)
HF by IBD subtype (subgroup)CDvs Reference individualsIR: 46.9 vs. 34.41.28 (1.20–1.36)
HF by IBD subtype (subgroup)UCvs Reference individualsIR: 50.1 vs. 39.71.14 (1.09–1.19)
HF by IBD subtype (subgroup)IBD-Uvs Reference individualsIR: 60.9 vs. 39.01.28 (1.16–1.42)
HF, sibling-controlled analysisIBDvs SiblingsSlightly attenuated association1.10 (1.03–1.19)

Original publication

Risk of heart failure in inflammatory bowel disease: a Swedish population-based study. Eur Heart J. Published 21 May 2024. doi:10.1093/eurheartj/ehae338

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.